Newsletter
Every new paper in this field, in your inbox.
A study of 790 patients with advanced pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CC) reveals strong mutation concordance (MCR) between circulating tumor DNA (ctDNA) and tissue next-generation sequencing (NGS). In PDAC, 65.4% showed shared alterations, while CC had 66.7%. Additionally, ctDNA could signal resistant clones:…
Surgeons now have clear guidance favoring routine intraoperative cholangiography (IOC) during laparoscopic cholecystectomy for benign biliary disease. Conditional recommendations highlight IOC's superiority over fluorescence imaging and confirm its use in both adult and pediatric patients. Additionally, laparoscopic ultrasound remains a viable option. The guidelines stem…
Child-Pugh scores reveal a sharp correlation between liver function and surgical outcomes in gastrointestinal cancer patients. Among 167,680 surgeries analyzed, those with a score of 9 faced significantly increased surgical mortality—31.8% after distal gastrectomy and 20.7% after right hemicolectomy. Even after adjusting for risk factors,…
Nearly 46% of hepatocellular carcinoma patients exhibited circulating tumor cells (CTCs) in the portal vein, surpassing hepatic vein detection rates. Portal vein CTC positivity linked to microscopic invasion, significantly reducing disease-free and overall survival. Notably, PD-L1-positive CTCs in this cohort correlated with dire prognoses. These…
Surgical treatment significantly improves overall, 1-year, and 3-year survival rates for metastatic pancreatic adenocarcinoma, particularly in patients with liver-only metastases. Compared to chemotherapy and palliative care, surgical options reduce mortality risk (HR: 0.42). Despite promising results, outcomes vary based on metastatic sites, with no survival…
The Fib-3 index demonstrates superior accuracy in predicting liver fibrosis and long-term outcomes in hepatocellular carcinoma patients over 65. An independent risk factor for recurrence-free survival, it outshines the conventional Fib-4 index by eliminating age-related biases. Effective risk stratification for 5-year survival hinges on its…
Surgical intervention for pancreatic adenocarcinoma markedly enhances survival rates in patients at all stages, except for those classified as stage IV with T4 or N1 classifications. A deep learning model, DeepSurv, demonstrated a robust c-index of 0.85 in predicting survival, with surgery notably lowering mortality…
Patients with high pre-treatment CA19-9 levels show significantly poorer prognoses than those with normal levels. Neoadjuvant treatment (NAT) markedly enhances survival for these patients, with optimal outcomes for those achieving normalized CA19-9 or sufficient reduction post-treatment. Stratification reveals that patients with levels under 296 u/ml…
A newly validated nomogram accurately predicts postoperative recovery outcomes for patients undergoing pancreaticoduodenectomy for invasive intraductal papillary mucinous neoplasm (IPMN). Analyzing data from 479 patients, it identifies four key predictors: severe COPD, hypertension, elevated INR, and prolonged operative time, achieving a textbook outcome in roughly…
The intricate vascular anatomy of the pancreas, rife with variations, profoundly impacts surgical and interventional outcomes. Key arterial and venous structures, including the superior pancreaticoduodenal arteries and the gastrocolic trunk, require careful consideration to ensure effective surgical planning. Advances in imaging technologies now allow for…
